Texas House Bill HB3836

Texas 2017 - 85th Regular

Caption

Relating to importing pharmaceuticals from a foreign country.

Impact

If enacted, HB 3836 would significantly change the landscape of pharmaceutical access in Texas, especially for patients who are unable to afford certain medications. By allowing the importation of approved foreign drugs, the state hopes to leverage global pharmaceutical markets to provide more options for healthcare providers and their patients. Additionally, the bill includes provisions that protect healthcare professionals from criminal and civil liability when importing drugs, as long as their actions are in good faith and within their professional scope.

Summary

House Bill 3836 seeks to amend the Texas Health and Safety Code by introducing a new chapter specifically focused on the importation of pharmaceuticals from foreign countries. This bill allows licensed pharmacists and physicians to legally obtain drugs from foreign pharmacies or manufacturers, provided that the drugs are approved by the United States Food and Drug Administration (FDA). The aim of this legislation is to enhance access to medications that may be unavailable or cost-prohibitive in the domestic market, thus addressing the needs of Texas residents for affordable medication alternatives.

Contention

While supporters of HB 3836 argue that it provides necessary relief for patients and fosters a competitive market for pharmaceuticals, critics express concerns regarding the potential risks associated with importing drugs. There are worries about the quality and safety of medications sourced from foreign entities, even when FDA-approved. Thus, the bill has sparked debate about the regulatory measures necessary to ensure that these drugs meet stringent safety standards and do not compromise patient health.